As we found that the ICOS expression is associated with a better prognosis for breast cancer patients, and positively correlated with immune cell sores, especially T-cell immune responses, but not for stromal cells, which suggests the varied role of ICOS expression in different tumors. This evidence concerns the gene ICOS and breast carcinoma.